Statistical evaluation of an acute dermal toxicity test using the dermal fixed dose procedure

Area of Science:

• Toxicology
• Chemical Safety Assessment
• Regulatory Science

Background:

• Conventional acute dermal toxicity testing (OECD Test Guideline 402) relies on animal death to determine the median lethal dose (LD50).
• There is a need for alternative methods that reduce animal use and suffering.
• The Globally Harmonised System of Classification and Labelling of Chemicals (GHS) requires accurate hazard classification.

Purpose of the Study:

• To describe and evaluate a new dermal fixed dose procedure (dermal FDP) as an alternative to OECD Test Guideline 402.
• To assess the statistical validity and performance of the dermal FDP using modeling.
• To compare the classification outcomes and animal usage of the dermal FDP with the conventional LD50 method.

Main Methods:

• The study describes the dermal FDP, a new OECD testing guideline.
• Statistical modeling was employed for validation, simulating various substance toxicities.
• The model calculated probabilities for GHS classifications and predicted animal deaths and usage.

Main Results:

• The dermal FDP was statistically validated, demonstrating its reliability.
• The procedure is predicted to result in significantly fewer animal deaths and suffering compared to OECD Test Guideline 402.
• Substances are classified under GHS with equal or greater stringency than with the LD50 method.

Conclusions:

• The dermal FDP is a viable and ethical alternative for assessing acute dermal toxicity.
• This new guideline aligns with the principles of reducing, refining, and replacing animal testing (3Rs).
• The dermal FDP provides robust GHS classification with improved animal welfare outcomes.